Get Started for FREE
Sign up with Facebook Sign up with Twitter
I don't have a Facebook or a Twitter account
 Your new post is loading...
Your new post is loading...
Scoop.it!
GlaxoSmithKline’s quadrivalent influenza vaccine has been granted marketing authorisation in Germany and the UK. The four-strain vaccine is the first to be approved in a European country for active immunisation of adults and children from three years of age for the prevention of influenza disease caused by the two influenza A and two influenza B virus subtypes contained within the vaccine. 
No comment yet.
Sign up to comment
|
Scoop.it!
The Guardian Protection offered by GSK malaria vaccine fades over time Reuters The disappointing results for RTS,S - the world's first potential malaria vaccine - raise further questions about whether it can make a difference in the fight against...
Ed Rybicki's insight:
Sad but true - just because you have a vaccine, doesn't mean it will work as you would like.
|
